Regeneus Revenue and Competitors

Pymble,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Regeneus's estimated annual revenue is currently $1.6M per year.(i)
  • Regeneus's estimated revenue per employee is $155,000

Employee Data

  • Regeneus has 10 Employees.(i)
  • Regeneus grew their employee count by -23% last year.

Regeneus's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Regeneus?

Regeneus Ltd (ASX: RGS) is a clinical-stage biotech company developing innovative first-in-class stem cell, exosome and immuno-oncology therapies that address significant unmet medical needs.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Regeneus News

2022-04-20 - Global Rheumatoid Arthritis Stem Cell Therapy Market 2022 ...

Mesoblast; Roslin Cells; Regeneus; ReNeuron Group; International Stem Cell Corporation; Takeda. The report explores the regional and country...

2022-04-17 - Canine Stem Cell Therapy Market Analysis, Research Study ...

VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos. Report overview:.

2022-04-17 - Veterinary Vaccine Market Is Booming Worldwide 2022-2028 ...

Veterinary Vaccine Market Is Booming Worldwide 2022-2028 | Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M46N/AN/A
#2
$13.6M9723%N/A
#3
$26.2M97-7%N/A
#4
$16.5M1147%N/A
#5
$19.9M122-9%N/A